BERLIN & COPENHAGEN--(BUSINESS WIRE)--MyoPax has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for its regenerative cell therapy in Exstrophy-Epispadias Complex ...
The Ca 2+ levels, released by agonist-induced activity of phospholipase C, determine which contractile pathway is activated. In the following subsections we discuss in some detail some of the steps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results